Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.42211 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.40955 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.40272 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.27929 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.36611 | 56 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.57259 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.47543 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.55471 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.41279 | 56 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.35581 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.40226 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.32853 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.39877 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.40031 | 56 |